Views & Analysis Rethinking drug discovery George Underwood speaks to R&D veteran Dr Paul-Peter Tak about how the drug discovery model needs to change.
News Most pharmas not ready for AI in customer engagement Pharma wants to use AI for digital engagement with healthcare professionals and patients, but most feel unprepared to forge ahead, says survey.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face